Advocacy activities promote awareness among policymakers of how nuclear medicine and molecular imaging improve patient outcomes. At the federal, state and regional levels, SNMMI continually makes the case to legislators, regulators and private payers for approval of proven new procedures and applications, as well as appropriate reimbursement to allow patient access to innovative new tests and treatments.
SNMMI is working cooperatively with peer organizations and industry to optimize reimbursement for nuclear medicine procedures. Staff and members are educating and raising awareness about a wide array of issues among legislators, regulators such as the Centers for Medicare and Medicaid Services and the Food and Drug Administration (FDA), and payers. In addition, SNMMI continues to provide support through its coding and reimbursement website, which is consulted more than 20,000 times annually.
Optimizing reimbursement.
SNMMI LogoValue Initiative logo